Consumer News Eli Lilly Pauses Antibody Trial After Unexplained Patient Reaction
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Eli Lilly Pauses Antibody Trial After Unexplained Patient Reaction is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
U.S. pauses Eli Lilly trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused by the U.S. Read More
Eli Lilly says other COVID-19 antibody drug trials ongoing after study halted for safety concern
Eli Lilly & Co on Wednesday said other trials of its experimental coronavirus antibody therapy remain on track after a government-run study testing the treatment in hospitalized COVID-19 patients was ... Read More
Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch
On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus